Key facts
| Price (PPV) | 12.40 MAD |
|---|---|
| Dispensing status | Unscheduled — no prescription needed |
| Composition (DCI) | paracétamolcaféine |
| Class | Analgesics |
| ATC code | N02BE01 |
| Manufacturer | AFRIC-PHAR |
| Presentation | Boîte de 16 |
| Nature | Médicament |
| Hospital price | 7.70 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement des douleurs modérées à intenses qui ne sont pas soulagées par l'aspirine, le paracétamol ou l'ibuprofène utilisé seul.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
Efdol Cafeine 500 mg / 50 mg (NOVOPHARMA) contains the same active substance as Algik 500 mg / 50 mg (Paracétamol | Caféine) at the same strength, but in a different pack: Boîte de 20 at 13.80 MAD, i.e. 0.69 MAD per unit against 0.78 MAD for Algik 500 mg / 50 mg. The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
Same pack size
| Product | Manufacturer | Pack | PPV | Unit price | Difference |
|---|---|---|---|---|---|
| Panalgic 500 mg / 50 mg | SOTHEMA | Boîte de 16 | 14 MAD | 0.88 / unit | — |
Other pack sizes
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Efdol Cafeine 500 mg / 50 mg | NOVOPHARMA | Boîte de 20 | 13.80 MAD | 0.69 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Algik 500 mg / 50 mg
Algik 500 mg / 50 mg belongs to the analgesics therapeutic class. In Morocco, this drug is marketed by AFRIC-PHAR and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Algik 500 mg / 50 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Algik 500 mg / 50 mg
Answers to common questions from Moroccan patients about this drug.